| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.37 | 0.02 |